MTIP is a self-described leading Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare. MTIP leverages its sector expertise to help scale up successful and sustainable healthtech businesses.

MTIP

MTIP is a leading Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare. We leverage our deep sector expertise to help the founders scale up successful and sustainable digital health businesses.

Blueprint Genetics

Join us in welcoming Lloyd Diamond as the new CEO of Nitinotes Surgical, bringing his extensive experience in medical devices to drive the company’s growth and innovation!

Excited to welcome Daniela Nienstedt and Benjamin Gilgen to MTIP's Board of Directors! Daniela brings nearly 20 years of consulting experience with a strong focus on private capital, and Benjamin’s expertise in strategic marketing and innovation will be invaluable as MTIP continues its growth journey. Welcome aboard! ✨

Read the full press release here: https://lnkd.in/di6HFyW4

#boardmembers #growth #MTIP

We are pleased to announce MTIP Fund II’s ninth platform investment in Hexarad, leading the €13 million growth round with reinvestment from existing shareholders.

Founded in 2016 and headquartered in London, UK, Hexarad’s radiology platform provides teleradiology services and software to customers in the UK, Ireland, and Saudi Arabia. Hexarad’s software suite covers an end-to-end radiology workflow including a proprietary radiology information system (RIS), Hexarad Edge integration engine, Hexarad Hub for urgent reporting and Hexarad Portal for auto-allocation. The teleradiology services offering provides teleradiology readings to the NHS and imaging centers across the UK and Ireland. The company has consistently achieved over 120% annual growth.
 
Katrin Vatiska, Investment Partner at MTIP states: “We are highly impressed by the founding team—Farzana Rahman, Sam Dumonteil, Jaymin Patel, and Amy Davis—and we are excited to partner with them for the next phase of growth. We see tremendous potential in Hexarad and are thrilled to support the scaling of their teleradiology services and the expansion of their software product offerings.”

Our €13 million investment will help Hexarad scale and solidify its position as the leading teleradiology services and software provider.

Read the full press release here: https://lnkd.in/dRUCsH2i 

#teleradiology #healthtech #portfoliocompany #newinvestment

MTIP Featured in PEI’s 2024 Healthcare Report 🩵

Artificial Intelligence is reshaping the landscape of healthtech investing, offering unprecedented opportunities for innovation and efficiency. At MTIP, we are proud to support companies that are at the forefront of this AI-driven revolution ✨

Our Managing Partner & Co-Founder, Christoph Kausch, was interviewed for this article, providing valuable insights into the strategic approaches necessary for success in this evolving field.

Discover more about how AI is driving the future of healthcare in our latest feature in Private Equity International’s 2024 Healthcare report.

Click the link below to read the full article 🔗

#HealthcareInnovation #AI #PrivateEquity #DigitalHealth #Healthtech #HealthtechInvesting

Carmel van den Berk Promoted to Investment Associate ✨

We are excited to share the news of Carmel's promotion to Investment Associate. Since joining MTIP in October 2023, Carmel has significantly contributed to our team. She has played a crucial role in evaluating investment opportunities and in supporting and bringing value to our portfolio companies.

We look forward to Carmel's continued achievements! 🩵

Check out her profile here: https://lnkd.in/dDHBXdSg

#MTIPteam #promotion #investmentteam

Natalia Surkova joins MTIP as a Finance Assistant ✨

Natalia's background includes working at the Ministry of Finance of Ukraine, where she was responsible for concluding double tax treaties and implementing international tax initiatives into Ukrainian legislation. She holds a degree in Management of Foreign Economic Activity from Krivoy Rog National Technical University in Ukraine and is fluent in English, Ukrainian, and Russian.
 
We're excited to have Natalia on board! 🙌

Check out her profile on our website:  https://lnkd.in/ddJa7N27

#MTIPteam #WelcomeToTheTeam

MTIP has been recognized as a “Great Place to Work”🌟

The valuable feedback we received from all team members will guide our ongoing improvements as a team, and we are committed to creating the best work environment possible.

The picture below was taken at our offsite in Flims last week, where we spent some time together as a team away from the office, focusing on team building and our culture, and developing measures based on the results of Great Place to Work Switzerland survey.

Learn more about us here: https://lnkd.in/dJRkgJvg 

#greatplacetowork #greatplacetoworkswitzerland #healthtech #employeewellbeing

We are pleased to welcome Jeanne Kehren as the new CEO of our portfolio company, LynxCare. Jeanne's extensive experience in healthcare data and pharmaceutical innovation at Novartis, Sanofi, and Bayer positions her to lead LynxCare into the next phase of growth. Join us in welcoming Jeanne to LynxCare! ✨

Global healthcare expenses are weighing heavily on global economies. In 2022, global healthcare spending reached $10 trillion, or 9.2% of global GDP, driven by aging populations, chronic conditions, inflation, rising wages, and workforce shortages.

Digitalization through healthcare technologies (healthtech) is transforming the industry by reducing costs, expanding access, and improving outcomes. The pandemic accelerated the adoption of digital health, digital pharma, and health IT, making healthtech one of Europe’s fastest-growing investment categories. In 2023, healthtech secured $3.3 billion in funding, ranking as Europe’s 7th most funded industry.

In our latest healthtech report, prepared in collaboration with Dealroom.co, we highlight key trends and opportunities in the European healthtech space, primarily covering the growth stage ✨

Read the highlights here: https://lnkd.in/dy8ypa3h

#healthtech #growthequity #growthfund #digitalhealth #healthcare

Our Investment Partner Katrin Vatiska will be a panelist at HLTH Europe for the insightful session: Ctrl+Alt+Defeat: Winning the Cyber Security Battle in Health 🔐🛡️👨💻🌐

In a world where data breaches are increasingly common, the stakes are even higher in healthcare. IBM's annual data loss report has listed healthcare as the most expensive industry in which to have a data breach for 13 consecutive years. This is not surprising given the sensitivity of the data involved.

As budgets become more strained, the need to learn from other industries that have achieved top-notch security becomes crucial. Join Katrin alongside Michel van Genderen, Ashley Mancuso and Dr. med. Markus Leyck Dieken, with Kaveh Safavi moderating, as they dive into strategies and insights to bolster cybersecurity in healthcare ✨

#HLTHEurope #healthIT #healthtech

Metric
Company Name	MTIP
Symbol
MSH ID	CH:MTIP
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital and Private Equity
Country	CH
Stage
Employee Count
Website	mtip.ch
LinkedIn	mtip-healthtech-investors
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CH:MTIP

MTIP

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue